Tci Gene (ROCO:6879) FCF Margin % : -14.93% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Tci Gene FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Tci Gene's Free Cash Flow for the six months ended in Dec. 2023 was NT$-27.5 Mil. Tci Gene's Revenue for the six months ended in Dec. 2023 was NT$184.0 Mil. Therefore, Tci Gene's FCF Margin % for the quarter that ended in Dec. 2023 was -14.93%.

As of today, Tci Gene's current FCF Yield % is 0.70%.

The historical rank and industry rank for Tci Gene's FCF Margin % or its related term are showing as below:

ROCO:6879' s FCF Margin % Range Over the Past 10 Years
Min: 4.4 Med: 22.16 Max: 46.48
Current: 4.4

During the past 5 years, the highest FCF Margin % of Tci Gene was 46.48%. The lowest was 4.40%. And the median was 22.16%.

ROCO:6879's FCF Margin % is ranked better than
82.29% of 1039 companies
in the Biotechnology industry
Industry Median: -139.09 vs ROCO:6879: 4.40

Tci Gene FCF Margin % Historical Data

The historical data trend for Tci Gene's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene FCF Margin % Chart

Tci Gene Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

46.48

16.44

22.16

22.42

4.40

Tci Gene Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial				40.07	8.09	42.75	28.13	-14.93

Competitive Comparison of Tci Gene's FCF Margin %

For the Biotechnology subindustry, Tci Gene's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tci Gene's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tci Gene's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Tci Gene's FCF Margin % falls into.

Tci Gene FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Tci Gene's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	14.683	/	333.855
	=	4.40 %

Tci Gene's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-27.477	/	183.992
	=	-14.93 %

Tci Gene FCF Margin % Related Terms

Thank you for viewing the detailed overview of Tci Gene's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tci Gene (ROCO:6879) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN

Website

https://www.genext.me

Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines